Remdesivir (Veklury®), a nucleotide analogue prodrug with broad-spectrum antiviral activity,
is approved for the treatment of coronavirus disease 2019 (COVID-19), the illness caused by …

Objective: We aimed to better understand the impact of the COVID-19 pandemic through
analysis of disruptions in a global, regional, and national status of COVID-19 vaccination …

Even though since the beginning of the COVID-19 pandemic, the literature became more
and more abundant on data and hypotheses about the various consequences on people's …

Background and objectives Remdesivir, an antiviral drug routinely used in the treatment of
COVID-19 has not yet received FDA approval for use in patients with advanced kidney …

Remdesivir is a novel antiviral drug, which is active against the SARS-CoV-2 virus.
Remdesivir is known to accumulate in the brain but it is not clear whether it influences the …

Marburg virus disease (MVD) is a lethal viral haemorrhagic fever caused by Marburg virus
(MARV) with a case fatality rate as high as 88%. There is currently no vaccine or antiviral …

Pharmacovigilance and medical product safety issues are important for all global citizens.
Previous studies have analyzed the disaster caused by thalidomide in 1961. In 1963, the 16 …

Пандемия COVID-19 бросила вызов новым этиотропным средствам, что привело к
экстренному перепрофилированию противомикробных и противовирусных препаратов …

Background: Remdesivir is being studied and used for treatment of coronavirus disease
2019 (COVID-19). Purpose: To update a previous review of remdesivir for adults with COVID …

The COVID-19 pandemic has posed a challenge for new etiotropic agents, leading to an
urgent repurposing of antimicrobial and antiviral drugs to treat a new infection based on the …